Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
Clinical trial NCT07073014 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07073014
- Sponsor
- BioMarin Pharmaceutical
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2040-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.